Drugs Controller General Of India Dcgi
- All
- News
- Videos
-
Only Processing Charges To Be Levied For Procuring Blood At Hospitals, Blood Banks: Drug Regulator
Hospitals and blood banks can now only charge processing fees for blood as the apex drug regulator has decided to do away with all other fees to check the practice of overcharging.
-
Sale Of False Version Of 2 Drugs To Be Monitored In India After WHO Alert
The Drugs Controller General of India has directed the drugs controllers of all states and Union territories to keep a strict vigil on the sale and distribution of falsified versions of two drugs.
-
Drugs Regulator Says Will Prioritise Making Regulation System Simpler
Drugs Controller General of India (DCGI) Rajeev Singh Raghuvanshi on Thursday said bringing down regulatory intervention in the system and making it simpler is a top priority for the organisation.
-
AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India
AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
-
Critical Drug Developed Using DRDO Technology Gets Regulator's Approval
A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on Tuesday.
-
Amazon, Flipkart, 20 Others Get Notice For Selling Drugs Without Licence
Amazon and Flipkart Health plus are among the 20 online sellers that have been issued show-cause notices by the Drugs Controller General of India (DCGI) over the online sale of drugs in violation of norms.
-
Rajeev Singh Raghuvanshi Appointed As Drugs Controller General Of India
The Union Public Service Commission (UPSC) has recommended the name of DrRajeev Singh Raghuvanshi as the new Drugs Controller General of India (DCGI).
-
Serum Institute To Launch India's First Cervical Cancer Vaccine
Serum Institute of India CEO Adar Poonawalla on Tuesday said the company plans to launch its indigenously-developed vaccine to treat cervical cancer in women later this year after Drugs Controller General of India gives market authorisation.
-
Serum Institute's Covid Vaccine Covovax Cleared For 7-11 Age Group
The Drugs Controller General of India (DCGI) on Tuesday approved Serum Institute's COVID-19 vaccine Covovax for restricted emergency use in children aged 7 to 11 years subject to certain conditions, official sources said.
-
Covaxin Cleared For 6-12 Age Group, Corbevax For 5-12-Year-Olds
The Drugs Controller General of India (DCGI) today gave emergency use authorisation to Bharat Biotech's Covaxin for children between the age group of 6-12 amid an uptick in the Covid cases in schools.
-
One-Shot Sputnik Light Vaccine Gets Emergency Use Approval In India
The Drugs Controller General of India (DCGI) has granted emergency-use permission to the single-dose Sputnik Light COVID-19 vaccine, informed Union Health Minister Mansukh Mandaviya on Sunday.
-
Proposal For Sputnik Light As Covid Booster Submitted To Drug Regulator
Drug major Dr Reddy's Laboratories has submitted a proposal to the Drugs Controller General of India (DCGI) to register Sputnik Light vaccine as a booster dose against COVID-19, a top company official has said.
-
Covid Vaccines Covishield, Covaxin Get Conditional Market Approval: Report
India's drug regulator has granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, Health Minister Mansukh Mandaviya said today.
-
Covaxin Cleared For Children Above 12 By Drug Regulator
Bharat Biotech's COVID-19 vaccine Covaxin has been approved for emergency use on children between the ages of 12 and 18 by the Drugs Controller General of India (DCGI), sources said.
-
Have Not Mandated Covid Vaccines At This Stage: Centre To Supreme Court
The Centre on Monday told the Supreme Court that it has not mandated for COVID-19 vaccines to be administered mandatorily at this stage and all data relating to clinical trial approved by Drugs Controller General of India (DCGI), and vaccination data
-
Only Processing Charges To Be Levied For Procuring Blood At Hospitals, Blood Banks: Drug Regulator
Hospitals and blood banks can now only charge processing fees for blood as the apex drug regulator has decided to do away with all other fees to check the practice of overcharging.
-
Sale Of False Version Of 2 Drugs To Be Monitored In India After WHO Alert
The Drugs Controller General of India has directed the drugs controllers of all states and Union territories to keep a strict vigil on the sale and distribution of falsified versions of two drugs.
-
Drugs Regulator Says Will Prioritise Making Regulation System Simpler
Drugs Controller General of India (DCGI) Rajeev Singh Raghuvanshi on Thursday said bringing down regulatory intervention in the system and making it simpler is a top priority for the organisation.
-
AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India
AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
-
Critical Drug Developed Using DRDO Technology Gets Regulator's Approval
A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on Tuesday.
-
Amazon, Flipkart, 20 Others Get Notice For Selling Drugs Without Licence
Amazon and Flipkart Health plus are among the 20 online sellers that have been issued show-cause notices by the Drugs Controller General of India (DCGI) over the online sale of drugs in violation of norms.
-
Rajeev Singh Raghuvanshi Appointed As Drugs Controller General Of India
The Union Public Service Commission (UPSC) has recommended the name of DrRajeev Singh Raghuvanshi as the new Drugs Controller General of India (DCGI).
-
Serum Institute To Launch India's First Cervical Cancer Vaccine
Serum Institute of India CEO Adar Poonawalla on Tuesday said the company plans to launch its indigenously-developed vaccine to treat cervical cancer in women later this year after Drugs Controller General of India gives market authorisation.
-
Serum Institute's Covid Vaccine Covovax Cleared For 7-11 Age Group
The Drugs Controller General of India (DCGI) on Tuesday approved Serum Institute's COVID-19 vaccine Covovax for restricted emergency use in children aged 7 to 11 years subject to certain conditions, official sources said.
-
Covaxin Cleared For 6-12 Age Group, Corbevax For 5-12-Year-Olds
The Drugs Controller General of India (DCGI) today gave emergency use authorisation to Bharat Biotech's Covaxin for children between the age group of 6-12 amid an uptick in the Covid cases in schools.
-
One-Shot Sputnik Light Vaccine Gets Emergency Use Approval In India
The Drugs Controller General of India (DCGI) has granted emergency-use permission to the single-dose Sputnik Light COVID-19 vaccine, informed Union Health Minister Mansukh Mandaviya on Sunday.
-
Proposal For Sputnik Light As Covid Booster Submitted To Drug Regulator
Drug major Dr Reddy's Laboratories has submitted a proposal to the Drugs Controller General of India (DCGI) to register Sputnik Light vaccine as a booster dose against COVID-19, a top company official has said.
-
Covid Vaccines Covishield, Covaxin Get Conditional Market Approval: Report
India's drug regulator has granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, Health Minister Mansukh Mandaviya said today.
-
Covaxin Cleared For Children Above 12 By Drug Regulator
Bharat Biotech's COVID-19 vaccine Covaxin has been approved for emergency use on children between the ages of 12 and 18 by the Drugs Controller General of India (DCGI), sources said.
-
Have Not Mandated Covid Vaccines At This Stage: Centre To Supreme Court
The Centre on Monday told the Supreme Court that it has not mandated for COVID-19 vaccines to be administered mandatorily at this stage and all data relating to clinical trial approved by Drugs Controller General of India (DCGI), and vaccination data
